Table 1A. Genetic animal models for the study of AMPK signaling pathway.
Animal model | Tissue specificity | Remarks | Reference |
---|---|---|---|
Knock-out mice
| |||
AMPKα1 | whole-body | (17) | |
AMPKα2 | whole-body | (18) | |
AMPKβ1 | whole-body | (B. Kemp)* | |
AMPKβ2 | whole-body | (B. Kemp)* | |
AMPKγ3 | whole-body | (65) | |
Alfpα2 | liver | use of Alfp-Cre | (26) |
α1KOAlfpα2 | whole-body α1 and liver α2 | use of Alfp-Cre | (24) |
AgRPα2 | hypothalamus (AgRP neurons) | use of AgRp-Cre | (124) |
POMCα2 | hypothalamus (POMC neurons) | use of POMC-Cre | (124) |
α1KOPOMCα2 | whole-body α1 and POMC α2 | use of POMC-Cre | (124) |
Muscle/heart LKB1 | skeletal and cardiac muscle | use of MCK-Cre | (7, 8, 152) |
Transgenic mice
| |||
AMPKα1R45A | skeletal and cardiac muscle | MCK promoter/AMPK-DN | (64) |
AMPKα2D157A | skeletal and cardiac muscle | MCK promoter/AMPK-DN | (64) |
AMPKα2R45A | skeletal and cardiac muscle | MCK promoter/AMPK-DN | (19) |
AMPKα2D157A | heart | α-MHC promoter/AMPK-DN | (85) |
AMPKγ1R70Q | skeletal muscle | α-actin promoter/AMPK-CA | (77) |
AMPKγ2 | heart | α-MHC promoter | (87, 88) |
AMPKγ2R302Q | heart | α-MHC promoter/AMPK-CA | (87) |
AMPKγ2N488I | heart | α-MHC promoter/AMPK-CA | (88, 89) |
AMPKγ2T400N | heart | α-MHC promoter/AMPK-CA | (91) |
AMPKγ2R531G | heart | α-MHC promoter/AMPK-CA | (90) |
AMPKγ3 | skeletal and cardiac muscle | MCK promoter | (65, 76) |
AMPKγ3R225Q | skeletal and cardiac muscle | MCK promoter/AMPK-CA | (65,76) |
Adenovirus-mediated gene transfer
| |||
Liver AMPKα2-CA | liver | Ad AMPKα2-CA infection | (21) |
Neuron AMPKα1-CA | hypothalamus | Ad AMPKα1-CA infection | (107) |
Neuron AMPKα1+α2-DN | hypothalamus | Ad AMPKα1 +α2-DN infection | (107) |
Liver LKB1 KO | liver | Ad Cre infection | (27) |
Ad, adenovirus; Alfp, albumin α-fetoprotein; AgRP, agouti-related protein; Cre, Cre recombinase; MCK, muscle creatine kinase; POMC, pro-opiomelanocortin; α-MHC, α-myosin heavy chain; AMPKα1-CA, AMPKα1 constitutively active form; AMPKα2-CA, AMPKα2 constitutively active form; AMPKα1+α2-DN, AMPKα1 and AMPKα2 dominant negative forms.
Bruce Kemp, personal communication.